364 related articles for article (PubMed ID: 38179168)
1. Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy.
Constantin M; Chifiriuc MC; Mihaescu G; Vrancianu CO; Dobre EG; Cristian RE; Bleotu C; Bertesteanu SV; Grigore R; Serban B; Cirstoiu C
Front Oncol; 2023; 13():1273516. PubMed ID: 38179168
[TBL] [Abstract][Full Text] [Related]
2.
Mougeot JC; Beckman MF; Langdon HC; Lalla RV; Brennan MT; Bahrani Mougeot FK
Front Microbiol; 2021; 12():794546. PubMed ID: 35116012
[TBL] [Abstract][Full Text] [Related]
3. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis.
Li R; Xiao L; Gong T; Liu J; Li Y; Zhou X; Li Y; Zheng X
Mol Oral Microbiol; 2023 Feb; 38(1):9-22. PubMed ID: 36420924
[TBL] [Abstract][Full Text] [Related]
4. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
5. Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
Chan JYK; Cheung MK; Lan L; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Cai L; Zhu H; Boon SS; Burk RD; Chan PKS; Chen Z
Oral Oncol; 2022 Dec; 135():106245. PubMed ID: 36375420
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus, tobacco, and poor oral hygiene can act synergetically, modulate the expression of the nuclear factor kappa B signaling pathway for the development and progression of head and neck cancer in the Pakistani population.
Sarwar S; Mulla M; Mulla M; Tanveer R; Sabir M; Sultan A; Malik SA
Chin Med J (Engl); 2022 Aug; 135(15):1829-1836. PubMed ID: 35838554
[TBL] [Abstract][Full Text] [Related]
7. Anti-cancer management of head and neck cancers and oral microbiome-what can we clinically obtain?
Makarewicz J; Kaźmierczak-Siedlecka K; Sobocki BK; Dobrucki IT; Kalinowski L; Stachowska E
Front Cell Infect Microbiol; 2024; 14():1329057. PubMed ID: 38481661
[TBL] [Abstract][Full Text] [Related]
8. Role of human papillomavirus in non-oropharyngeal head and neck cancers.
Combes JD; Franceschi S
Oral Oncol; 2014 May; 50(5):370-9. PubMed ID: 24331868
[TBL] [Abstract][Full Text] [Related]
9. Potential oncogenic roles of mutant-p53-derived exosomes in the tumor-host interaction of head and neck cancers.
Azulay EE; Cooks T; Elkabets M
Cancer Immunol Immunother; 2020 Feb; 69(2):285-292. PubMed ID: 31897662
[TBL] [Abstract][Full Text] [Related]
10. Family History of Head and Neck Cancers.
Li X; Koskinen AI; Hemminki O; Försti A; Sundquist J; Sundquist K; Hemminki K
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439270
[TBL] [Abstract][Full Text] [Related]
11. Oral microbiome and risk of incident head and neck cancer: A nested case-control study.
Wu Z; Han Y; Wan Y; Hua X; Chill SS; Teshome K; Zhou W; Liu J; Wu D; Hutchinson A; Jones K; Dagnall CL; Hicks BD; Liao L; Hallen-Adams H; Shi J; Abnet CC; Sinha R; Chaturvedi A; Vogtmann E
Oral Oncol; 2023 Feb; 137():106305. PubMed ID: 36610232
[TBL] [Abstract][Full Text] [Related]
12. HPV Associated Head and Neck Cancer.
Spence T; Bruce J; Yip KW; Liu FF
Cancers (Basel); 2016 Aug; 8(8):. PubMed ID: 27527216
[TBL] [Abstract][Full Text] [Related]
13. Head and Neck Carcinoma Immunotherapy: Facts and Hopes.
Whiteside TL
Clin Cancer Res; 2018 Jan; 24(1):6-13. PubMed ID: 28751445
[TBL] [Abstract][Full Text] [Related]
14. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
Pyeon D; Newton MA; Lambert PF; den Boon JA; Sengupta S; Marsit CJ; Woodworth CD; Connor JP; Haugen TH; Smith EM; Kelsey KT; Turek LP; Ahlquist P
Cancer Res; 2007 May; 67(10):4605-19. PubMed ID: 17510386
[TBL] [Abstract][Full Text] [Related]
15. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment.
Campisi G; Giovannelli L
Head Neck Oncol; 2009 Mar; 1():8. PubMed ID: 19331691
[TBL] [Abstract][Full Text] [Related]
16. The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers.
Morais E; Kothari S; Chen YT; Roberts CS; Gómez-Ulloa D; Fenoll R; Lara N; Pavón MÀ; Waterboer T; Mehanna H; Giuliano AR; Mirghani H; Alemany L
Contemp Clin Trials; 2022 Apr; 115():106631. PubMed ID: 34838716
[TBL] [Abstract][Full Text] [Related]
17. Systematic review on oral microbial dysbiosis and its clinical associations with head and neck squamous cell carcinoma.
Ting HSL; Chen Z; Chan JYK
Head Neck; 2023 Aug; 45(8):2120-2135. PubMed ID: 37249085
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
[TBL] [Abstract][Full Text] [Related]
19. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study.
Laprise C; Madathil SA; Schlecht NF; Castonguay G; Soulières D; Nguyen-Tan PF; Allison P; Coutlée F; Hier M; Rousseau MC; Franco EL; Nicolau B
Oral Oncol; 2017 Jun; 69():56-61. PubMed ID: 28559021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
